I
GSK icon

InvesTrust’s GSK GSK Stock Holding History

InvesTrust’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.52M Sell
28,970
-815
-3% -$43.1K 0.58% 54
2026
Q1 		$1.64M Sell
29,785
-238
-0.8% -$12.9K 0.69% 54
2025
Q4 		$1.47M Sell
30,023
-1,538
-5% -$71.7K 0.57% 53
2025
Q3 		$1.36M Buy
31,561
+44
+0.1% +$1.72K 0.5% 57
2025
Q2 		$1.21M Sell
31,517
-73,092
-70% -$2.79M 0.47% 59
2025
Q1 		$4.05M Buy
104,609
+3,311
+3% +$121K 1.11% 46
2024
Q4 		$3.42M Buy
+101,298
New +$3.65M 0.95% 46

Other funds holding GSK

JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
MHI
Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return

InvesTrust's GSK Position: Q2 2026 in Review

InvesTrust reduced its GSK (GSK) stake by 2.7% in Q2 2026, selling an estimated $43.1K and leaving 28,970 shares worth $1.52M. The position accounts for 0.58% of the portfolio, ranked #54.

InvesTrust first reported a position in GSK in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.05M in Q1 2025. 439 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • InvesTrust held 28,970 shares of GSK worth $1.52M as of Q2 2026.
  • InvesTrust sold 815 GSK shares in Q2 2026, an estimated $43.1K.
  • GSK made up 0.58% of InvesTrust's portfolio in Q2 2026, its #54 holding.
  • InvesTrust first reported a position in GSK in Q4 2024 and has held it in 7 quarters since.
  • InvesTrust's GSK position peaked at $4.05M in Q1 2025.
  • 439 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on InvesTrust's 13F filing for Q2 2026, filed 14 Jul 2026.